A Randomized, Double-Blind, Active-Controlled, Parallel Group, Stratified, Multicenter, 12-Week Study to Evaluate the Safety and Efficacy after Multiple Dosing of Investigational Budesonide HFA Metered Dose Inhalers Compared with Conventional Budesonide CFC Metered Dose Inhalers (Pulmicort) in Patients with Asthma.

Study identifier:D5252C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Double-Blind, Active-Controlled, Parallel Group, Stratified, Multicenter, 12-Week Study to Evaluate the Safety and Efficacy after Multiple Dosing of Investigational Budesonide HFA Metered Dose Inhalers Compared with Conventional Budesonide CFC Metered Dose Inhalers (Pulmicort) in Patients with Asthma.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Aug 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria